Screening and Phenotypical Characterization of <i>Schistosoma mansoni</i> Histone Deacetylase 8 (<i>Sm</i>HDAC8) Inhibitors as Multistage Antischistosomal Agents
Fulvio Saccoccia(National Research Council), Giovina Ruberti(National Research Council), Giuseppe Campiani(University of Siena), Nicola Relitti(University of Siena), Stefania Butini(University of Siena), Manfred Jung(University of Freiburg), Giulia Chemi(University of Siena), Roberto Gimmelli(National Research Council), Caterina Cavella(University of Siena), Simone Brogi(University of Pisa), Giuliana Papoff(National Research Council), Daniel Herp(University of Freiburg), Margherita Brindisi(University of Naples Federico II), Sandra Gemma(University of Siena), A. Prasanth Saraswati(University of Siena), Alessandra Guidi(University of Pisa), Johanna Senger(University of Freiburg)
Cited by 27
Related Papers
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
|Nature Communications|2015|297
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
|European Journal of Medicinal Chemistry|2017|119
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
|Journal of Medicinal Chemistry|2019|115
4‐Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading
|Angewandte Chemie International Edition|2013|109